You need to be logged in to view this video

Opportunity for Investment in the Multi-Billion Dollar Veterinary Cancer Market

Released on Thursday, August 25, 2016•TECHNOLOGY

Share
Facebook Twitter LinkedIn SMS

Current medication and treatments for veterinary cancer are limited and largely ineffective. The veterinary health market for companion animals has grown steadily by 4% - 6% annually. Introduction of a natural scorpion based product for cancer treatment is a disruptive technology with strong investment return.

Ralph Salvagno

Petlife Pharmaceuticals, CEO & Chairman of the Board

Dr. Ralph Salvagno is chairman of the Board and CEO of Petlife Pharmaceuticals and a practicing orthopaedic surgeon. He brings his scientific background, business acumen, and love of pets to the challenge of cancer treatment in our companion animals.